Watch both videos below. This is the sixth season of Behind The Counter, with the series having amassed over 2.5million views to date in total. Other shops set to be featured include Bangor’s ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in over-the-counter decongestants ... that actually may help: nasal irrigation devices.

They might have gone to school together, but there is no love lost between two of the Gold Coast’s most controversial figures, with conman Peter Foster launching an extraordinary spray at Clive ...

Read more Fitbit gets burned: Fitbit settled with the U.S. Consumer Product Safety Commission over a long-standing defect that caused some wearers to sustain burns. Fitbit will pay a $12.25 ...

Explore the world in the golden age of off-roading. Drive iconic vehicles from the 60s to 80s by yourself or with friends through challenging trails and beautiful scenery.

Students attempted to climb over a milk counter to escape, she said. "Honestly, I decided to help people before I helped myself because I know if that was me struggling to get out, I would want ...

Funselektor, the developer behind art of rally, has revealed a co-op off-road exploration game titled: over the hill. "Explore the world in the golden age of offroading. Drive iconic vehicles from ...

Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...